| Valproic acid | Approved Investigational | AMOTL1 | 154810 |
upregulated | Valproic Acid results in increased expression of AMOTL1 mRNA | 11q21 | |
| Valproic acid | Approved Investigational | AMPH | 273 |
upregulated | Valproic Acid results in increased expression of AMPH mRNA | 7p14.1 | |
| Valproic acid | Approved Investigational | AMY2B | 280 |
downregulated | Valproic Acid results in decreased expression of AMY2B mRNA | 1p21.1 | |
| Valproic acid | Approved Investigational | AMZ2 | 51321 |
downregulated | Valproic Acid results in decreased expression of AMZ2 mRNA | 17q24.2 | |
| Valproic acid | Approved Investigational | AMZ2P1 | 201283 |
downregulated | Valproic Acid results in decreased expression of AMZ2P1 mRNA | 17q24.1 | |
| Valproic acid | Approved Investigational | ANAPC1 | 64682 |
downregulated | Valproic Acid results in decreased expression of ANAPC1 mRNA | 2q13 | |
| Valproic acid | Approved Investigational | ANAPC10 | 10393 |
downregulated | Valproic Acid results in decreased expression of ANAPC10 mRNA | 4q31.21 | |
| Valproic acid | Approved Investigational | ANAPC16 | 119504 |
downregulated | Valproic Acid results in decreased expression of ANAPC16 mRNA | 10q22.1 | |
| Valproic acid | Approved Investigational | ANAPC5 | 51433 |
upregulated | Valproic Acid results in increased expression of ANAPC5 mRNA | 12q24.31 | |
| Valproic acid | Approved Investigational | ANAPC7 | 51434 |
upregulated | Valproic Acid results in increased expression of ANAPC7 mRNA | 12q24.11 | |
| Valproic acid | Approved Investigational | ANG | 283 |
upregulated | Valproic Acid results in increased expression of ANG mRNA | 14q11.2 | |
| Valproic acid | Approved Investigational | ANGEL2 | 90806 |
downregulated | Valproic Acid results in decreased expression of ANGEL2 mRNA | 1q32.3 | |
| Valproic acid | Approved Investigational | ANGPT1 | 284 |
upregulated | Valproic Acid results in increased expression of ANGPT1 mRNA | 8q23.1 | |
| Valproic acid | Approved Investigational | ANGPT2 | 285 |
upregulated | Valproic Acid results in increased expression of ANGPT2 mRNA | 8p23.1 | |
| Valproic acid | Approved Investigational | ANGPTL3 | 27329 |
downregulated | Valproic Acid results in decreased expression of ANGPTL3 mRNA | 1p31.3 | |
| Valproic acid | Approved Investigational | ANGPTL4 | 51129 |
upregulated | Valproic Acid results in increased expression of ANGPTL4 mRNA | 19p13.2 | |
| Valproic acid | Approved Investigational | ANK2 | 287 |
downregulated | Valproic Acid results in decreased expression of ANK2 mRNA | 4q25-q26 | |
| Valproic acid | Approved Investigational | ANK2 | 287 |
upregulated | Valproic Acid results in increased expression of ANK2 mRNA | 4q25-q26 | |
| Valproic acid | Approved Investigational | ANK3 | 288 |
downregulated | Valproic Acid results in decreased expression of ANK3 mRNA | 10q21.2 | |
| Valproic acid | Approved Investigational | ANK3 | 288 |
upregulated | Valproic Acid results in increased expression of ANK3 mRNA | 10q21.2 | |
| Valproic acid | Approved Investigational | ANKDD1A | 348094 |
downregulated | Valproic Acid results in decreased expression of ANKDD1A mRNA | 15q22.31 | |
| Valproic acid | Approved Investigational | ANKDD1A | 348094 |
upregulated | Valproic Acid results in increased expression of ANKDD1A mRNA | 15q22.31 | |
| Valproic acid | Approved Investigational | ANKEF1 | 63926 |
upregulated | Valproic Acid results in increased expression of ANKEF1 mRNA | 20p12.2 | |
| Valproic acid | Approved Investigational | ANKH | 56172 |
upregulated | Valproic Acid results in increased expression of ANKH mRNA | 5p15.2 | |
| Valproic acid | Approved Investigational | ANKHD1 | 54882 |
upregulated | Valproic Acid results in increased expression of ANKHD1 mRNA | 5q31.3 | |